About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Interview 19 Jan 2023

Interview: Proscia talks about digital pathology

Pathalys Pharma brings in $150M for SHPT trials

Hundreds of genetic discoveries from FinnGen study 

BioInvent receives funding for blood cancer treatments

Funding for industry-first cancer screening technology 

Vésale Bioscience receives €1.8M grant for AMR phage project

ADVERTISEMENT

Is Copenhagen the world capital of life science?

Colombia foodtech acceleration program includes startups in first cohort

Ascletis phase I COVID trial progressing

Poolbeg expands POLB 001 into oncology

Multus Biotechnology closes $9.5M funding to bring cultivated meat closer to price parity

EverImmune launches trial for oncobiotic lung and kidney cancer drug candidate

ADVERTISEMENT